Skip to content

Clinical trials

Phase 2/3 Lung Neoplasms trials in Germany

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Lung Neoplasms Phase: Phase 2/3 Country / region: Germany Clear all

9 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20001
20021
20051
20061
20112
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed3
Recruiting3
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Bristol-Myers Squibb2
Auron Healthcare GmbH1
BioNTech SE1
European Organisation for Research and Treatment of Cancer - EORTC1
NCIC Clinical Trials Group1
Sanofi1
Synta Pharmaceuticals Corp.1
Transgene1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Lung Neoplasms9
Carcinoma, Non-Small-Cell Lung6
Adenocarcinoma of Lung1
Adenocarcinoma, Bronchiolo-Alveolar1
Colonic Neoplasms1
Esophageal Neoplasms1
Gallbladder Neoplasms1
Gastrointestinal Neoplasms1
Genital Neoplasms, Female1
Liver Neoplasms1

Trials

Showing 1 to 9 of 9. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.